title: High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients.
authors.affiliation: a Department of Oncology , Helsinki University Central Hospital , Helsinki , Finland.
authors.forename: Leena
authors.initials: L
authors.lastname: Vehmanen
authors.affiliation: b Department of Oral and Maxillofacial Surgery , Helsinki University Central Hospital , Helsinki , Finland.
authors.forename: Juho
authors.initials: J
authors.lastname: Suojanen
authors.affiliation: b Department of Oral and Maxillofacial Surgery , Helsinki University Central Hospital , Helsinki , Finland.
authors.forename: Risto
authors.initials: R
authors.lastname: Kontio
authors.affiliation: a Department of Oncology , Helsinki University Central Hospital , Helsinki , Finland.
authors.forename: Tapio
authors.initials: T
authors.lastname: Utriainen
authors.affiliation: a Department of Oncology , Helsinki University Central Hospital , Helsinki , Finland.
authors.forename: Carl
authors.initials: C
authors.lastname: Blomqvist
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D000069448:Denosumab / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D008297:Male; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D010020:Osteonecrosis / Q000139:chemically induced*; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D012189:Retrospective Studies
chemical_list: D050071:Bone Density Conservation Agents; D000069448:Denosumab